Pharmacy Benefits Management Strategic Healthcare Group

Following the initial drug class review on ophthalmic prostaglandin analogs, the Department of Veterans Affairs (VA) awarded a national contract to travoprost. A retrospective cohort analysis was performed on patients that were switched from latanoprost or bimatoprost to travoprost between August 2003 and April 2005. ................
................